Loading
WC
No insider purchase over the last 90 days. The latest, by LAM CHING KUI, was filed 11 Apr 2022.
Wai Chun Bio-Technology Ltd.: what insiders have been doing
Wai Chun Bio-Technology Ltd., classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to HKEX. The past year has been quiet: not a single insider filing for Wai Chun Bio-Technology Ltd. The previous disclosure was published on 9 January 2023.
Our records for Wai Chun Bio-Technology Ltd. go back to 2017, with 13 purchases and 8 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Fuller H B Co and Culp Inc. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Insider Decl.
24
Thresholds
n/a
Buy Volume
€12M
13 ops. · all time
Sell Volume
€536,451
8 ops. · all time
Since the insiders bought
- -73.5%Entry HK$0.40 · Close at T+365 HK$0.11
- -70.9%Entry HK$2.20 · Close at T+365 HK$0.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,305 of 26,280 companies
19.0
score / 100
Value22
Quality16
FCF yld-16%
Earn yld-9.4%
EV/EBITDA14.0x
ROE·
Gross mgn9.5%
Net mgn-3.9%
Debt/EBITDA5.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
HK$0.41
Analyst consensus
Income statement
RevenueHK$377.2M
Gross profitHK$36M10% margin
EBITDAHK$17.9M5% margin
Net income-HK$14.6M-1.2% margin
Valuation
Beta1.29
Balance sheet & cash
Market capHK$155.6M
Total debtHK$95.2M
Free Cash Flow-HK$24.6M
Profitability & ownership
ROA1.9%
% insiders76.9%
% institutions0.0%
Last declaration on 9 January 2023
Declarations24 total
162,706,853 sharesShareXHKGHKEX:DA20230109E00502
30,000,000 shares@ HK$0.038ShareXHKGHKEX:DA20230109E00500
2,599,506,432 sharesShareXHKGHKEX:DA20220719E00600
1,340,000,000 shares@ HK$0.0542.3% of flowShareXHKGHKEX:DA20220411E00061
Canonical exit: 6 Jul 2022 (T+90)
21,696,000 shares@ HK$0.050.6% of flowShareXHKGHKEX:DA20220221E00246
420,000,000 shares@ HK$0.0512.5% of flowShareXHKGHKEX:DA20211026E00403
Canonical exit: 20 Jan 2022 (T+90)
1,360,659,506 shares@ HK$0.032426.8% of flowShareXHKGHKEX:DA20200716E00513
30,000,000 shares@ HK$0.0342100.0% of flowShareXHKGHKEX:DA20200715E00524
Canonical exit: 12 Oct 2020 (T+90)
26,000,000 shares@ HK$0.03550.6% of flowShareXHKGHKEX:DA20200713E00520
1,300,000 shares@ HK$0.0940.1% of flowShareXHKGHKEX:DA20200710E00510
9,000,000 shares@ HK$0.03430.2% of flowShareXHKGHKEX:DA20200710E00509
11,260,000 shares@ HK$0.03990.6% of flowShareXHKGHKEX:DA20200131E00172
20,000,000 shares@ HK$0.0380.5% of flowShareXHKGHKEX:DA20190123E00319
2,000,000 shares@ HK$0.04450.1% of flowShareXHKGHKEX:DA20190121E00293
Canonical exit: 18 Apr 2019 (T+90)
6,100,000 shares@ HK$0.04460.2% of flowShareXHKGHKEX:DA20190121E00270
Canonical exit: 17 Apr 2019 (T+90)
15,210,000 shares@ HK$0.03990.4% of flowShareXHKGHKEX:DA20190114E00464
Canonical exit: 11 Apr 2019 (T+90)
7,660,000 shares@ HK$0.04230.2% of flowShareXHKGHKEX:DA20190111E00199
Canonical exit: 9 Apr 2019 (T+90)
29,500,000 shares@ HK$0.0410.7% of flowShareXHKGHKEX:DA20190109E00383
Canonical exit: 8 Apr 2019 (T+90)
60,410,000 shares@ HK$0.03451.3% of flowShareXHKGHKEX:DA20190109E00366
Canonical exit: 7 Apr 2019 (T+90)
67,530,000 shares@ HK$0.0291.2% of flowShareXHKGHKEX:DA20190107E00358
Canonical exit: 3 Apr 2019 (T+90)
40,000,000 shares@ HK$0.03250.8% of flowShareXHKGHKEX:DA20190107E00363
Canonical exit: 4 Apr 2019 (T+90)
54,440,000 shares@ HK$0.03071.0% of flowShareXHKGHKEX:DA20190103E00463
Canonical exit: 2 Apr 2019 (T+90)
64,750,000 shares@ HK$0.03181.2% of flowShareXHKGHKEX:DA20190103E00437
Canonical exit: 31 Mar 2019 (T+90)
320,000,000 shares@ HK$0.059.3% of flowShareXHKGHKEX:DA20171209E00026
24 of 24 declarations
About Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the development of biopharmaceutical products. It focuses on research and production of innovative solutions for the healthcare sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
